Ursprung des Netzwerks ersten Grades von Anna E. Crivici
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO.
13
| Subsidiary | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anna E. Crivici
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | General Counsel | |
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GENOMIC HEALTH, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Decision Options LLC
 Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Investment Managers | Analyst-Equity Corporate Officer/Principal | |
| IMMUNOME, INC. | Biotechnology | Director/Board Member | |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Biotechnology | Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
HealthTronics, Inc.
 HealthTronics, Inc. Medical SpecialtiesHealth Technology HealthTronics, Inc. provides healthcare and technology support services. The firm focuses on urologist partnership opportunities, surgical and capital equipment maintenance and anatomical pathology services. Its products portfolio include urology devices, including lithotripters and surgical treatment lasers. The company was founded by Argil J. Wheelock in 1972 and is headquartered in Austin, TX. | Medical Specialties | Director/Board Member | |
| FIBROGEN, INC. | Pharmaceuticals: Major | General Counsel | |
| University of Utah | College/University | Doctorate Degree | |
| ZOETIS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Bates College | College/University | Undergraduate Degree | |
| California State University-Sacramento | College/University | Undergraduate Degree | |
| Colgate University | College/University | Undergraduate Degree | |
| Creighton University | College/University | Doctorate Degree | |
| Yale University | College/University | Doctorate Degree | |
| Mount Saint Mary's University | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree | |
| University of New Hampshire | College/University | Doctorate Degree Doctorate Degree | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member Private Equity Investor | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | General Counsel | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
| Astra Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
| The Polycystic Kidney Disease Research Foundation | Corporate Officer/Principal | ||
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| IGNYTA INC | Biotechnology | Director/Board Member | |
| Connecticut School of Law University Of | College/University | Graduate Degree | |
| Tulane University School of Public Health & Tropical Medicine | College/University | Doctorate Degree | |
| PURETECH HEALTH PLC | Biotechnology | Director/Board Member | |
| Neuropharma Advisors LLC | Corporate Officer/Principal | ||
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
Alivio Therapeutics, Inc.
 Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder |
Statistik
International
| Vereinigte Staaten | 51 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 14 |
| Finance | 5 |
Operativ
| Director/Board Member | 47 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 13 |
| Chief Tech/Sci/R&D Officer | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John LaMattina | 20 |
| Alan Levin | 17 |
| James Bristol | 17 |
| Craig Saxton | 16 |
| Mostafa Analoui | 13 |
| Jeffrey Ives | 13 |
| R. Wayne Frost | 10 |
| Alan Krasner | 7 |
| John F. Bender | 6 |
| John R. Kirk | 6 |
| Catherine Knupp | 6 |
| Michael D. Wider | 5 |
| Paul Aldridge | 5 |
- Börse
- Insiders
- Anna E. Crivici
- Unternehmensverbindungen
